9.—(1) Item 1 of the First Schedule to the principal Regulations is amended —(a) | by deleting the words “365th day (including that day) after the start of the period.” in the fourth column relating to paragraph (2) and substituting the following paragraphs:“(a) | 365th day (including that day) after the start of the period, unless paragraph (b) applies; | (b) | 120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine.”; and |
|
| (b) | by inserting, immediately after paragraph (5), the following paragraph:“ | | | | | | | | | (6) | One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
”. |
|
|
(2) Item 2 of the First Schedule to the principal Regulations is amended —(a) | by deleting the words “365th day (including that day) after the start of the period.” in the fourth column relating to paragraph (2) and substituting the following paragraphs:“(a) | 365th day (including that day) after the start of the period, unless paragraph (b) applies; | (b) | 120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine.”; and |
|
| (b) | by inserting, immediately after paragraph (5), the following paragraph:“ | | | |
---|
| | | |
---|
| (6) | One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
”. |
|
|
|
(3) Item 3 of the First Schedule to the principal Regulations is amended —(a) | by deleting the words “365th day (including that day) after the start of the period.” in the fourth column relating to paragraph (2) and substituting the following paragraphs:“(a) | 365th day (including that day) after the start of the period, unless paragraph (b) applies; | (b) | 120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine.”; and |
|
| (b) | by inserting, immediately after paragraph (5), the following paragraph:“ | | | |
---|
| | | |
---|
| (6) | One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
”. |
|
|
|
(4) Item 5 of the First Schedule to the principal Regulations is amended —(a) | by deleting the words “365th day” in the fourth column relating to paragraphs (1), (2), (3), (4) and (5) and substituting in each case the words “120th day”; and | (b) | by inserting, immediately after paragraph (5), the following paragraphs:“ | | | | | | | | | (6) | Three doses of the defined approved vaccine opposite, administered at least 17 days apart for the first 2 doses and at least 86 days apart between the second and third doses. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (7) | Two doses of the defined approved vaccine opposite administered at least 17 days apart, followed by a third dose either of Sinovac‑Coronavac COVID‑19 vaccine or another approved vaccine that is not a defined approved vaccine, where the second and third doses are administered at least 86 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (8) | One dose of the defined approved vaccine opposite, followed by a dose of another approved vaccine that is not a defined approved vaccine, followed by a dose of a defined approved vaccine, where each dose is administered at least 17 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (9) | One dose of the defined approved vaccine opposite, followed by a dose of Sinovac‑Coronavac COVID‑19 vaccine where each dose is administered at least 17 days apart, followed by a third dose of any approved vaccine, where the second and third doses are administered at least 86 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (10) | Two doses of the defined approved vaccine opposite administered, at least 17 days apart to a recovered individual at least 28 days after the recovered individual first tested positive for SARS‑CoV‑2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1). |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (11) | Two doses of the defined approved vaccine opposite administered at least 17 days apart, to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1). |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (12) | One dose of the defined approved vaccine opposite, followed by a dose of Sinovac‑Coronavac COVID‑19 vaccine administered at least 17 days apart, to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual mentioned in paragraph (10). |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (13) | One dose of the defined approved vaccine opposite, followed by a dose of Sinovac‑Coronavac COVID‑19 vaccine administered at least 17 days apart, to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual mentioned in paragraph (11). |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (14) | At least 3 doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (6) to (13). |
|
| 14th day after the last dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
”. |
|
|
|
(5) Item 6 of the First Schedule to the principal Regulations is amended —(a) | by deleting the words “365th day” in the fourth column relating to paragraphs (1), (2), (3), (4) and (5) and substituting in each case the words “120th day”; and | (b) | by inserting, immediately after paragraph (5), the following paragraphs:“ | | | | | | | | | (6) | Three doses of the defined approved vaccine opposite, administered at least 13 days apart for the first 2 doses and at least 86 days apart between the second and third doses. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (7) | Two doses of the defined approved vaccine opposite administered at least 13 days apart, followed by a third dose either of Sinopharm COVID‑19 vaccine or another approved vaccine that is not a defined approved vaccine, where the second and third doses are administered at least 86 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (8) | One dose of the defined approved vaccine opposite, followed by a dose of another approved vaccine that is not a defined approved vaccine, followed by a dose of a defined approved vaccine, where each dose is administered at least 17 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (9) | One dose of the defined approved vaccine opposite, followed by a dose of Sinopharm COVID‑19 vaccine, where each dose is administered at least 17 days apart, followed by a third dose of any approved vaccine, where the second and third doses are administered at least 86 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (10) | Two doses of the defined approved vaccine opposite administered, at least 13 days apart to a recovered individual at least 28 days after the recovered individual first tested positive for SARS‑CoV‑2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1). |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (11) | Two doses of the defined approved vaccine opposite administered at least 13 days apart to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1). |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (12) | One dose of the defined approved vaccine opposite, followed by a dose of Sinopharm COVID‑19 vaccine administered at least 17 days apart, to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual mentioned in paragraph (10). |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (13) | One dose of the defined approved vaccine opposite, followed by a dose of Sinopharm COVID‑19 vaccine administered at least 17 days apart, to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual mentioned in paragraph (11). |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (14) | At least 3 doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (6) to (13). |
|
| 14th day after the last dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
”. |
|
|
|
(6) Item 7 of the First Schedule to the principal Regulations is amended —(a) | by deleting the words “365th day (including that day) after the start of the period.” in the fourth column relating to paragraph (2) and substituting the following paragraphs:“(a) | 365th day (including that day) after the start of the period, unless paragraph (b) applies; | (b) | 120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine.”; and |
|
| (b) | by inserting, immediately after paragraph (5), the following paragraph:“ | | | |
---|
| | | |
---|
| (6) | One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
”. |
|
|
|
(7) The First Schedule to the principal Regulations is amended by inserting, immediately after item 7, the following item:“ | | | | | | | | 8. | COVOVAX COVID‑19 vaccine or Nuvaxovid (Novavax COVID‑19 vaccine) |
|
| (1) | Two doses, administered at least 17 days apart. |
|
| 14th day after the second dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (2) | One dose of the approved vaccine opposite, followed by a dose of another approved vaccine administered at least 17 days after the firstmentioned dose is administered. |
|
| 14th day after the second dose is administered in accordance with the second column. |
| (a) | 365th day (including that day) after the start of the period, unless paragraph (b) applies; |
|
(b) | 120th day (including that day) after the start of the period where the other approved vaccine is a single dose of a defined approved vaccine. |
|
| | (3) | One dose of the approved vaccine opposite, administered to a recovered individual at least 28 days after the recovered individual first tested positive for SARS‑CoV‑2, if he or she is a recovered individual because of having undergone a test or tests described in paragraph (a)(i) or (ii) of the definition of “recovered individual” in regulation 2(1). |
|
| 14th day after the dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (4) | One dose of the approved vaccine opposite, administered to a recovered individual after recovery from the COVID‑19 infection, if he or she is a recovered individual because of having undergone a test described in paragraph (a)(iii) of the definition of “recovered individual” in regulation 2(1). |
|
| 14th day after the dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (5) | Such number of doses and administered at such intervals as may be specified by the Director, where initial administration is not in accordance with paragraphs (1) to (4). |
|
| 14th day after the last dose is administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
| | (6) | One dose of the approved vaccine opposite, followed by 2 doses of any defined approved vaccine or combination of defined approved vaccines, where the respective doses are each administered at least 17 days apart. |
|
| Upon the third dose being administered in accordance with the second column. |
| 365th day (including that day) after the start of the period. |
|
”. |
|
|
|